CORZZ — Core Scientific, Inc. Tranche 2 Warrants

Core Scientific Q1 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $79.5 million, down 16% sequentially, primarily due to mining disconnections and relocations as the company transitions to high-density colocation.
• Adjusted EBITDA: Negative $6.1 million.
• Bitcoin Production: 719 Bitcoin mined in Q1, down from 974 in Q4 2024.
• Capital Expenditures (CapEx): Approximately $90 million, with over half funded by CoreWeave.
• Liquidity: Approximately $780 million in cash, cash equivalents, and Bitcoin.

2. Strategic Updates and Business Highlights

• CoreWeave Contracts: Central to growth strategy, providing a take-or-pay fixed price contract structure that minimizes capital outlay and aligns execution risks.
• Customer Base Diversification: Focus on expanding beyond CoreWeave, with a growing pipeline of large enterprise customers showing interest in high-density infrastructure.
• Construction Progress: Significant advancements in building out 570 megawatts of capacity for CoreWeave, particularly at the Denton facility, which is expected to host one of the largest GPU clusters in North America.
• New Site Development: Plans to add approximately 300 megawatts of billable capacity by 2027 and target an additional 400 megawatts through new site development.

3. Forward Guidance and Outlook

• Capacity Goals: Aim to deliver 250 megawatts to CoreWeave by the end of 2025 and 590 megawatts by early 2027.
• Customer Base Strategy: Target to reduce CoreWeave's contribution to less than 50% of total billable capacity by the end of 2028.
• Market Positioning: Confidence in capturing a significant share of the emerging AI-driven infrastructure market.

4. Challenges and Points of Concern

• Revenue Decline: The sequential decrease in revenue and negative EBITDA reflects ongoing challenges during the transition from mining to colocation.
• Market Dynamics: Potential impacts from tariffs on CapEx requirements, which may lead to increased lease rates.
• Customer Contracting: While there is optimism about enterprise demand, the company has not yet signed new customers, indicating a risk in execution and market penetration.

5. Notable Q&A Insights

• Customer Demand: Large enterprises are showing increased interest and quicker timelines for contract signing compared to hyperscalers, which may provide a more stable revenue stream.
• CoreWeave Concentration: Management believes that the execution of the CoreWeave contracts will enhance confidence among other potential hyperscale clients rather than deter them.
• Construction Updates: Monthly updates on construction milestones will be provided to ensure transparency and maintain investor confidence.
• Long-Term Strategy: The company is focused on strategic M&A opportunities that align with its core competencies and enhance its market position in high-density colocation.

Overall, while Core Scientific is navigating a challenging transition period, it remains optimistic about its strategic positioning in the AI infrastructure market and is focused on executing its growth plans effectively.